A phase I dose-escalation study of apatorsen (OGX-427), an...

  • Main
  • 2016 / 02
  • A phase I dose-escalation study of apatorsen (OGX-427), an...

A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancers

Chi, K. N., Yu, E. Y., Jacobs, C., Bazov, J., Kollmannsberger, C., Higano, C. S., Mukherjee, S. D., Gleave, M. E., Stewart, P. S., Hotte, S. J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw068
Date:
February, 2016
File:
PDF, 161 KB
english, 2016
Conversion to is in progress
Conversion to is failed